Odyssey Health (ODYY) EPS (Basic) (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -698.22% |
| Oct 31, 2025 | 62.42% |
| Jul 31, 2025 | -315.94% |
| Apr 30, 2025 | -14.36% |
| Jan 31, 2025 | 78.98% |
| Oct 31, 2024 | 92.86% |
| Jul 31, 2024 | -1,300.00% |
| Apr 30, 2024 | -107.14% |
| Jan 31, 2024 | 1,500.00% |
| Oct 31, 2023 | 0.00% |
| Jul 31, 2023 | 50.00% |
| Apr 30, 2023 | 0.00% |
| Jan 31, 2023 | 33.33% |
| Oct 31, 2022 | -50.00% |
| Jul 31, 2022 | 50.00% |
| Apr 30, 2022 | -100.00% |
| Jan 31, 2022 | 0.00% |
| Oct 31, 2021 | 33.33% |
| Jul 31, 2021 | 76.92% |
| Apr 30, 2021 | -1,200.00% |
| Jan 31, 2021 | 0.00% |
| Oct 31, 2020 | 66.67% |
| Jul 31, 2020 | -200.00% |
| Apr 30, 2020 | 0.00% |
| Jan 31, 2020 | 50.00% |
| Oct 31, 2019 | 94.12% |
| Jan 31, 2019 | -45.42% |
| Oct 31, 2018 | -34.02% |
| Jul 31, 2018 | -37.55% |
| Apr 30, 2018 | 71.45% |
| Jan 31, 2018 | 49.67% |
| Oct 31, 2017 | -657.08% |
| Jul 31, 2017 | 18.99% |
| Apr 30, 2017 | -156.67% |
| Jan 31, 2017 | -42.43% |
| Oct 31, 2016 | 40.63% |
| Jul 31, 2016 | -350.09% |
| Apr 30, 2016 | 49.18% |
| Jan 31, 2016 | 35.57% |
| Oct 31, 2015 | -3.89% |
| Jul 31, 2015 | 43.39% |
| Apr 30, 2015 | 16.12% |
| Jan 31, 2015 | -16.53% |